NEUTRALIZING GP41 ANTIBODIES AND THEIR USE
Germany
12847241.2
Filed on 2012-11-07
12847241.2
Filed on 2012-11-07
Neutralizing Antibodies to GP120 and Their Use
South Africa
2017/06155
Filed on 2016-03-18
2017/06155
Filed on 2016-03-18
NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE
US Patent 10,562,960
Filed on 2017-09-19
Filed on 2017-09-19
Neutralizing Antibodies to GP120 and Their Use
India
201737032671
Filed on 2016-03-18
201737032671
Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use
European Patent
16716979.6
Filed on 2016-03-18
16716979.6
Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use
China
201680028822.8
Filed on 2016-03-18
201680028822.8
Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use
Canada
2980005
Filed on 2016-03-18
2980005
Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use
Australia
2016235541
Filed on 2016-03-18
2016235541
Filed on 2016-03-18
TREATMENT OF TUMORS BY INHIBITION OF CD300F
Patent Cooperation Treaty
PCT/US2017/056192
Filed on 2017-10-11
PCT/US2017/056192
Filed on 2017-10-11
METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE
Patent Cooperation Treaty
PCT/US2017/051413
Filed on 2017-09-13
PCT/US2017/051413
Filed on 2017-09-13